menu toggle

Podcast: Insulin biosimilars part 1

By AmerisourceBergen

In part one of a two-part series on insulin biosimilars, we’ll talk about what these new drugs could mean for the category.
You can also listen and subscribe wherever you get your podcasts, like Apple or Spotify.
Continue the conversation
Contact our biosimilars experts to learn more about our solutions for this important product category.